Loading clinical trials...
Loading clinical trials...
A Study of Mesenchymal Stem Cells as a Treatment in Patients With Acute Respiratory Distress Syndrome Caused by COVID-19
Conditions
Interventions
Mesenchymal Stem Cells derived from Wharton Jelly of Umbilical cords
Locations
1
Mexico
Instituto de Medicina Regenerativa
Tijuana, Estado de Baja California, Mexico
Start Date
April 16, 2020
Primary Completion Date
February 15, 2025
Completion Date
November 15, 2025
Last Updated
March 6, 2024
NCT06631287
NCT05101213
NCT04565665
NCT06871293
NCT04978571
NCT06082518
Lead Sponsor
Instituto de Medicina Regenerativa
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions